Formosa Laboratories, Inc. Statistics
Formosa Laboratories, Inc. (4746) Stock Statistics & Valuation Metrics
Total Valuation
Formosa Laboratories, Inc. has a market cap or net worth of TWD 5.26B. The enterprise value is TWD 8.92B.
- Market Cap
- TWD 5.26B
- Enterprise Value
- TWD 8.92B
Share Statistics
Formosa Laboratories, Inc. has 120,255,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 120,255,970
- Owned by Insiders
- ―
- Owned by Institutions
- 0.54%
Financial Efficiency
Formosa Laboratories, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.07%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.07%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 86.63M
- Profits Per Employee
- 7.88M
- Employee Count
- 56
- Asset Turnover
- 0.35
- Inventory Turnover
- 1.64
Valuation Ratios
The current PE Ratio of Formosa Laboratories, Inc. is 11.26. Formosa Laboratories, Inc.’s PEG ratio is 0.01.
- PE Ratio
- 11.26
- PS Ratio
- 1.16
- PB Ratio
- 0.75
- Price to FCF
- -14.84
- Price to Operating Cash Flow
- 6.79
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Formosa Laboratories, Inc. had revenue of 4.85B and earned 441.11M in profits. Earnings per share was 3.67.
- Revenue
- 4.85B
- Gross Profit
- 2.03B
- Operating Income
- 803.18M
- Pretax Income
- 501.75M
- Net Income
- 441.11M
- EBITDA
- 1.35B
- Earnings Per Share (EPS)
- 3.67
Cash Flow
In the last 12 months, operating cash flow was 821.58M and capital expenditures -1.18B, giving a free cash flow of -362.17M billion.
- Operating Cash Flow
- 821.58M
- Free Cash Flow
- -362.17M
- Free Cash Flow per Share
- -2.90
Dividends & Yields
Formosa Laboratories, Inc. pays an annual dividend of ―, resulting in a dividend yield of 6.86%
- Dividend Per Share
- ―
- Dividend Yield
- 6.86%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.74%
- Earnings Yield
- 8.53%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- -28.28%
- 50-Day Moving Average
- 46.93
- 200-Day Moving Average
- 49.72
- Relative Strength Index (RSI)
- 32.08
- Average Volume (3m)
- 644.08K
Important Dates
Formosa Laboratories, Inc. upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Formosa Laboratories, Inc. as a current ratio of 1.91, with Debt / Equity ratio of 46.53%
- Current Ratio
- 1.91
- Quick Ratio
- 1.32
- Debt to Market Cap
- 0.55
- Net Debt to EBITDA
- 1.83
- Interest Coverage Ratio
- 24.25
Taxes
In the past 12 months, Formosa Laboratories, Inc. has paid 105.72M in taxes.
- Income Tax
- 105.72M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Formosa Laboratories, Inc. EV to EBITDA ratio is 5.42, with an EV/FCF ratio of -21.32.
- EV to Sales
- 1.66
- EV to EBITDA
- 5.42
- EV to Free Cash Flow
- -21.32
- EV to Operating Cash Flow
- 9.40
Balance Sheet
Formosa Laboratories, Inc. has TWD 2.07B in cash and marketable securities with TWD 3.21B in debt, giving a net cash position of -TWD 1.14B billion.
- Cash & Marketable Securities
- TWD 2.07B
- Total Debt
- TWD 3.21B
- Net Cash
- -TWD 1.14B
- Net Cash Per Share
- -TWD 9.47
- Tangible Book Value Per Share
- TWD 63.61
Margins
Gross margin is 41.35%, with operating margin of 14.95%, and net profit margin of 10.25%.
- Gross Margin
- 41.35%
- Operating Margin
- 14.95%
- Pretax Margin
- 10.77%
- Net Profit Margin
- 10.25%
- EBITDA Margin
- 30.70%
- EBIT Margin
- 18.58%
Analyst Forecast
The average price target for Formosa Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.71%
- EPS Growth Forecast
- ―
